
Panitumumab + Mfolfox6 Versus Bevacizumab + Mfolfox6 As First-Line Treatment of Wild-Type Ras Metastatic Colorectal Cancer: A Cost-Effectiveness Analysis from the Brazilian Private Healthcare System Perspective
dos Santos, RF, Coutinho, MB, Haas, LVolume:
18
Journal:
Value in Health
DOI:
10.1016/j.jval.2015.09.260
Date:
November, 2015
Fichier:
PDF, 53 KB
2015